Côd QR

Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case–Control Study

Long COVID is a complex condition affecting quality of life, with limited therapeutic options. We investigated the occurrence of long COVID in subjects receiving early therapy with monoclonal antibodies (mAbs) or antivirals to reduce the risk of COVID-19 progression. In this retrospective study we e...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Antonio Cimellaro, Desirée Addesi, Michela Cavallo, Francesco Spagnolo, Edoardo Suraci, Raffaella Cordaro, Ines Spinelli, Francesco Passafaro, Manuela Colosimo, Medea Pintaudi, Carmelo Pintaudi, on behalf of the CATAnzaro LOng COVID (CATALOCO) Study Group
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2022-12-01
Cyfres:Biomedicines
Pynciau:
long COVID
post-COVID syndrome
COVID-19
SARS-CoV-2
monoclonal antibodies
antivirals
Mynediad Ar-lein:https://www.mdpi.com/2227-9059/10/12/3135
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg